Clinical Trial Update: Repinotan in Patients With Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial of Repinotan in patients with acute ischemic stroke has completed, according to a Bayer-sponsored clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Repinotan (repinotan)

Snippet

Sponsor: Bayer | Conditions: Stroke, Acute Ischemic Stroke | Phase 2 | Status: COMPLETED